Phase Ib Clinical Trial of Roflumilast Added to Standard Chemoimmunotherapy for High-risk Diffuse Large B-cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2019
Price : $35 *
At a glance
- Drugs Roflumilast (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 06 Nov 2019 Results assessing safety and tolerability of Roflumilast and R-CHOP as first line therapy in Diffuse Large B Cell Lymphoma Patients released at the 61st Annual Meeting and Exposition of the American Society of Hematology
- 10 Jun 2019 Planned End Date changed from 30 Jan 2020 to 30 Dec 2020.
- 10 Jun 2019 Planned primary completion date changed from 30 Nov 2019 to 30 Jun 2020.